This list is based on the watchlists of people on Stock Events who follow 4574.TSE. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Taiko Pharmaceutical Co.,Ltd. operates primarily in the pharmaceutical sector and the field of infection prevention. The company manufactures and distributes various over-the-counter medications, including its well-known Seirogan and Seirogan Toi-A brands, which are formulated to alleviate symptoms such as loose stools, diarrhea, vomiting, and ailments stemming from food or water contamination. Additionally, it provides specific tablets for diarrhea relief and quasi-pharmaceuticals like the Trumpet Intestinal Regulator BF. In its infection control segment, Taiko Pharmaceutical produces and supplies a range of sanitation products under the Cleverin brand to wholesalers. This includes the Cleverin generator, a device engineered to emit low concentrations of chlorine dioxide gas. The company also leverages its proprietary Cleverin technology by supplying it through original equipment manufacturer (OEM) agreements and engaging in joint product development ventures with other businesses. Its products are exported to several countries, including the United States, Canada, Thailand, Vietnam, Malaysia, and Mongolia. Taiko Pharmaceutical Co.,Ltd. was founded in 1946 and is headquartered in Osaka, Japan.
Show more...
FAQ
What is Taiko Pharmaceutical stock price today?▼
The current price of 4574.TSE is ¥255 JPY — it has increased by +0.39% in the past 24 hours. Watch Taiko Pharmaceutical stock price performance more closely on the chart.
What is Taiko Pharmaceutical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Tokyo Stock Exchange exchange Taiko Pharmaceutical stocks are traded under the ticker 4574.TSE.
Is Taiko Pharmaceutical stock price growing?▼
4574.TSE stock has fallen by -3.04% compared to the previous week, the month change is a +3.24% rise, over the last year Taiko Pharmaceutical has showed a -18.01% decrease.
What is Taiko Pharmaceutical market cap?▼
Today Taiko Pharmaceutical has the market capitalization of 12.91B
When is the next Taiko Pharmaceutical earnings date?▼
Taiko Pharmaceutical is going to release the next earnings report on November 06, 2026.
What were Taiko Pharmaceutical earnings last quarter?▼
4574.TSE earnings for the last quarter are 2.73 JPY per share, whereas the estimation was N/A JPY resulting in a N/A surprise. The estimated earnings for the next quarter are N/A JPY per share.
What is Taiko Pharmaceutical revenue for the last year?▼
Taiko Pharmaceutical revenue for the last year amounts to 2.64B JPY.
What is Taiko Pharmaceutical net income for the last year?▼
4574.TSE net income for the last year is 44M JPY.
Does Taiko Pharmaceutical pay dividends?▼
Yes, 4574.TSE dividends are paid semi-annual. The last dividend per share was 3.3 JPY. As of today, Dividend Yield (FWD)% is 2.75%.
How many employees does Taiko Pharmaceutical have?▼
As of September 05, 2026, the company has 220 employees.
In which sector is Taiko Pharmaceutical located?▼
Taiko Pharmaceutical operates in the Health & Wellness sector.
When did Taiko Pharmaceutical complete a stock split?▼
The last stock split for Taiko Pharmaceutical was on March 30, 2020 with a ratio of 3:1.
Where is Taiko Pharmaceutical headquartered?▼
Taiko Pharmaceutical is headquartered in Osaka, Japan.